Alzheimer's disease remains one of the most challenging neurodegenerative disorders to treat, despite decades of research and investment in drug development. The Alzheimer's disease age of onset varies, but most cases are diagnosed in individuals over 65, with Alzheimer's by age showing an increasing prevalence among older populations. Understanding why Alzheimer's happens is key to developing...

  The Alzheimer's disease landscape is evolving rapidly, driven by the dual challenges of an aging population and the urgent need for novel therapies for Alzheimer's disease. As the number of people affected by Alzheimer's continues to rise globally, the disease is becoming one of the most significant health concerns of our time. The rising incidence of Alzheimer's and the escalating...